Market Tracker

11/27 6:05pm ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

8.94
Data as of Nov 26
 +0.04 / +0.45%
Today’s Change
6.52
Today|||52-Week Range
11.47
+18.57%
Year-to-Date

Today’s Trading

Previous close8.90
Today’s open8.86
Day’s range8.86 - 9.00
Volume179,110
Average volume (3 months)390,986
Market cap$383.8M
Dividend yield--
Data as of 4:00pm ET, 11/26/2014

Growth & Valuation

Earnings growth (last year)-6.62%
Earnings growth (this year)+103.62%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+712.09%
P/E ratioNM
Price/Sales19.98
Price/Book10.68

Competitors

 Today’s
change
Today’s
% change
DVAXDynavax Technologies...+0.72+5.01%
RVNCRevance Therapeutics...+0.05+0.30%
TKMRTekmira Pharmaceutic...-0.18-1.10%
PTXPernix Therapeutics ...+0.04+0.38%
Data as of 3:59pm ET, 11/26/2014

Financials

Last reporting dateNovember 11, 2014
EPS forecast (this quarter)$0.32
Annual revenue (last year)$12.0M
Annual profit (last year)-$92.3M
Net profit margin-767.73%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts